Literature DB >> 9176212

Regulation and translocation of ATP-dependent apical membrane proteins in rat liver.

Z C Gatmaitan1, A T Nies, I M Arias.   

Abstract

The bile canalicular membrane contains four specific ATP-dependent transport processes that are involved in secretion of bile acids, non-bile acid organic anions (mrp1), phospholipids (mdr2), and organic cations (mdr3). The aim of this study was to determine how the canalicular presence of these transport proteins is regulated. Canalicular membrane vesicles (CMV) were prepared from livers of rats treated with taurocholate (TC) and/or dibutyryl-adenosine 3',5'-cycle monophosphate (DBcAMP) with and without pretreatment with colchicine. Transport studies were performed with radiolabeled substrates. Changes in the relative amounts of transport proteins were determined by Western blots. Compared with controls, the specific activity of each of the transport processes was enhanced 1.5- and 3-fold with TC and DBcAMP treatments, respectively. Western blots revealed the same increases with mdr2 and mdr3. Pretreatment of rats with colchicine prevented these responses fully with TC treatment, whereas only partial prevention was obtained with DBcAMP treatment. Besides the ATP-dependent transporters, the relative specific activities of the canalicular membrane ectoenzyme markers, leucine aminopeptidase and gamma-glutamyltranspeptidase, were also affected the same way. These results suggest that TC and DBcAMP increase the specific activity of the canalicular ATP-dependent transport proteins and some canalicular membrane ectoenzymes by stimulating an increase in the relative amounts of these proteins in the membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176212     DOI: 10.1152/ajpgi.1997.272.5.G1041

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Integration of preclinical and clinical data with pharmacokinetic modeling and simulation to evaluate fexofenadine as a probe for hepatobiliary transport function.

Authors:  Brandon Swift; Xianbin Tian; Kim L R Brouwer
Journal:  Pharm Res       Date:  2009-06-04       Impact factor: 4.200

Review 2.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 3.  Physiological and molecular biochemical mechanisms of bile formation.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 5.  Physiology of bile secretion.

Authors:  Alejandro Esteller
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

6.  AKAP350 Is involved in the development of apical "canalicular" structures in hepatic cells HepG2.

Authors:  Stella M Mattaloni; Elena Kolobova; Cristián Favre; Raúl A Marinelli; James R Goldenring; Maria C Larocca
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 7.  The bile salt export pump.

Authors:  Bruno Stieger; Yvonne Meier; Peter J Meier
Journal:  Pflugers Arch       Date:  2006-10-19       Impact factor: 3.657

8.  p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2.

Authors:  Christopher M Schonhoff; Se Won Park; Cynthia R L Webster; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-24       Impact factor: 4.052

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

10.  Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways.

Authors:  P Milkiewicz; M G Roma; E Elias; R Coleman
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.